Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
MCF 10A | GSK2334470 | 0.01 | 1.0078 | 0.00230 |
MCF 10A | GSK2334470 | 0.031622777 | 1.0359 | -0.00307 |
MCF 10A | GSK2334470 | 0.031622777 | 1.0398 | -0.00049 |
MCF 10A | GSK2334470 | 0.031622777 | 1.0183 | 0.00048 |
MCF 10A | GSK2334470 | 0.1 | 1.0286 | -0.00148 |
MCF 10A | GSK2334470 | 0.1 | 1.0101 | 0.00203 |
MCF 10A | GSK2334470 | 0.1 | 1.0337 | 0.00018 |
MCF 10A | GSK2334470 | 0.316227766 | 1.0280 | -0.00287 |
MCF 10A | GSK2334470 | 0.316227766 | 1.0275 | 0.00101 |
MCF 10A | GSK2334470 | 0.316227766 | 1.0450 | 0.00049 |
MCF 10A | GSK2334470 | 1.0 | 1.0183 | -0.00302 |
MCF 10A | GSK2334470 | 1.0 | 1.0224 | 0.00266 |
MCF 10A | GSK2334470 | 1.0 | 1.0121 | 0.00114 |
MCF 10A | GSK2334470 | 3.16227766 | 1.0315 | -0.00414 |
MCF 10A | GSK2334470 | 3.16227766 | 1.0087 | 0.00078 |
MCF 10A | GSK2334470 | 3.16227766 | 1.0243 | 0.00089 |
MCF 10A | GSK2334470 | 10.0 | 0.8974 | -0.00266 |
MCF 10A | GSK2334470 | 10.0 | 0.8830 | 0.00040 |
MCF 10A | GSK2334470 | 10.0 | 0.9729 | 0.00049 |
MCF 10A | Ribociclib | 0.001 | 0.9023 | -0.00232 |
MCF 10A | Ribociclib | 0.001 | 0.9133 | -0.00028 |
MCF 10A | Ribociclib | 0.001 | 0.9141 | 0.00067 |
MCF 10A | Ribociclib | 0.003162278 | 0.8916 | -0.00282 |
MCF 10A | Ribociclib | 0.003162278 | 0.9013 | 0.00011 |
MCF 10A | Ribociclib | 0.003162278 | 0.8761 | -0.00064 |